Pinktober Sock-Hop Charity Gala on Friday September 30 at

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Pinktober Sock-Hop Charity Gala on Friday September 30 at Four Winds New Buffalo

NEW BUFFALO, MI--(Marketwired - Aug 4, 2016) - The Pokagon Band of Potawatomi Indians' Four Winds® Casinos are pleased to announce it will host a Pinktober Sock-Hop Charity Gala that will raise money for the Southwest Michigan community of Susan G. Komen®. The 1950s themed gala will be held at 7 p.m. Eastern on Friday, September 30 at Four Winds New Buffalo's Silver Creek Event Center. Tickets include admission into the event, pink socks, an open bar, and food provided by Hard Rock Cafe Four Winds. Live music will be provided. The event will feature the presentation of the first annual Denise Bohn Award, honoring the late breast cancer activist. Hotel packages and event sponsorships are also available.

Tickets can be purchased beginning on Friday, August 5 at 11 a.m. Eastern exclusively through the Ticketmaster® Web site, www.ticketmaster.com , or by calling (800)745-3000. Ticket prices for the event start at $125 plus applicable fees, with a portion of the ticket sales going to the Southwest Michigan community of Susan G. Komen. All proceeds from the silent and live auction also go to Susan G. Komen. Hotel packages are also available for the night of the Pinktober Sock-Hop that includes a one night hotel stay on Friday, September 30 and admission into the event. Hotel packages, which include two tickets to the event, are available for $368 and must be bought through Ticketmaster.

Denise Bohn was the co-host of "Denise and Johnny in the Morning," on 98.3 FM The Coast in Benton Harbor, Mich. Denise was also the development director for the Southwest Michigan community of Susan G. Komen and tirelessly worked as a partner with Hard Rock Cafe Four Winds on its annual Pinktober concert series. The first annual Denise Bohn Award will honor a local breast cancer activist.

There are several opportunities to sponsor the Pinktober Sock-Hop Charity Gala. A $500 sponsorship includes four complimentary tickets and the company's name prominently displayed on a table and in the event program. A $1,000 sponsorship includes eight complimentary tickets; the company's logo, name and mission statement highlighted in event program; and the benefits listed in the previous level. A $2,500 sponsorship includes 12 complimentary tickets; a special thank you with a company logo in event program; and the benefits listed in the previous levels. A $5,000 sponsorship includes 20 complimentary tickets; a welcome table at the event to co-brand with Susan G. Komen Michigan; a special thank you from stage acknowledging the company as premier sponsor; and the benefits listed in the previous levels.

Sponsorships are also available for the program book. An advertisement on the front cover or back cover is available for $500; a full page advertisement inside the program is available for $400; and a half page advertisement inside the program is available for $225. Each program book sponsorship includes two complimentary tickets. Please call Elaina Leaureaux at (269)926-5366 to purchase a sponsorship.

Reservations and Information To make a hotel reservation at Four Winds New Buffalo or for more information on Four Winds New Buffalo, Four Winds Hartford, or Four Winds Dowagiac, please call (866)-4WINDS1, (866)494-6371 or visit www.fourwindscasino.com . Additionally, be sure to like Four Winds on Facebook at www.facebook.com/fourwindscasino and follow on Twitter at www.twitter.com/fourwindscasino .

About Susan G. Komen Michigan Komen Michigan is an independent, local non-profit organization that is dedicated to combating breast cancer. Seventy-five percent of the organization's net proceeds go towards programs and funding grants to local hospitals and community organizations that provide breast health education, screenings, diagnostics and survivorship programs for underserved men and women in Michigan. The remaining 25 percent of net proceeds funds global, leading-edge research focused on the prevention of, and cures for, breast cancer. Komen Michigan's mission is to save lives and end breast cancer forever by empowering people, ensuring quality of care for all, and energizing science to find the cures. For more information call (616)752-8262 or visit www.komenmichigan.org .

About Susan G. Komen Susan G. Komen is the world's largest breast cancer organization, funding more breast cancer research than any other nonprofit while providing real-time help to those facing the disease. Since its founding in 1982, Komen has funded more than $889 million in research and provided $1.95 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide. Komen was founded by Nancy G. Brinker, who promised her sister, Susan G. Komen, that she would end the disease that claimed Suzy's life. Visit www.komen.org or call 1-877 GO KOMEN. Connect on social at ww5.komen.org/social.

Media Contacts: Joshua Taustein Dresner Corporate Services (312)780-7219 jtaustein@dresnerco.com David Gutierrez Dresner Corporate Services (312)780-7204 dgutierrez@dresnerco.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

Updated Category News Views 218

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Continue Reading
Retirement Dreams Dashed: 61% Withdraw Early

Updated Category News Views 298

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Continue Reading
WeaveGrid Powers EVConnectNC: Charging Incentives Launched

Updated Category News Views 160

Transforming Utilities with EVConnectNC In a fresh move by WeaveGrid, North Carolina's Electric Cooperatives have teamed up to roll out EVConnectNC. This innovative program aims to manage the burgeoning demand for electric vehicle (EV) charging in rural and suburban areas under North Carolina's cooperative umbrella. Think of it as a smart way to handle new loads without...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 159

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 61

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 225

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 126

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 321

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
PASCAL's Holiday Gift Edit: Timeless Watches Shine

Updated Category News Views 273

Fresh Sparkle for the Holidays Well, here we are again, staring down the barrel of another holiday season. And what do you know, PASCAL is out with its 2026 Holiday Gift Edit, like clockwork. This is the kind of stuff they’re good at—capturing a moment, slapping some color on it, and calling it a game-changer. Launching on November 14, this edit nods to their Timeless...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 28

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading

Top 5 Most Recently Viewed Articles

McKinney's New Consumer PR Practice Sparks Marketing Buzz

Updated Category News Views 217

Market Dynamics Shifting: McKinney's Bold Move Let’s cut to the chase: McKinney’s launching a consumer PR practice—big deal, right? Well, hold your horses. This ain't just another agency spitting out press releases. They’re bringing in Jae Siercks, a heavy hitter from Weber Shandwick, to lead the charge. This kind of strategy echoes back to the days of the dot-com...

Continue Reading
Pariveda's Commitment: Winning Social Impact Partner Award

Updated Category News Views 218

Pariveda Recognized as Social Impact Partner of the Year Pariveda is proud to announce its recognition as the winner of the 2025 Geography and Global AWS Partner Award, highlighting its significant role as an innovator in the technology space. This prestigious award showcases the dedication of AWS Partners worldwide in advancing solutions using Amazon Web Services (AWS)....

Continue Reading
Eric A. Seiff: Celebrated Advocate in Criminal Defense for 2024

Updated Category News Views 179

Back in 2024, Eric A. Seiff was recognized among America’s Top 100 Criminal Defense Attorneys—a title only given to the absolute cream of the crop, with fewer than 0.5% of practicing attorneys making the cut. You gotta appreciate that level of distinction; it ain't just about being good—it’s about years spent fighting tooth and nail for what’s right in a...

Continue Reading
Wells Fargo Raises Price Target for Morgan Stanley Stock

Updated Category News Views 147

Wells Fargo Adjusts Morgan Stanley's Stock Outlook Recently, Wells Fargo reviewed its stance on Morgan Stanley (NYSE: MS), increasing the price target from $95.00 to $107.00. While this adjustment is a positive sign, the firm decided to keep an Underweight rating on the stock. The increase in the price target comes after Morgan Stanley's performance in the third quarter,...

Continue Reading
Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief

Updated Category News Views 218

Raytone Biotech Begins RTP-008 Clinical Trial for Dry Eye Relief Raytone Biotech, a clinical-stage biotechnology company focused on innovative ophthalmic therapies, recently achieved a significant milestone by successfully completing the first patient dosing in its clinical trial for RTP-008. This new therapy is purposefully designed for those suffering from dry eye...

Continue Reading